Disclosure of Relevant Financial Relationships with Commercial Interests

USF Health endorses the standards of the ACCME, ANCC, and ACPE and all applicable accrediting organizations that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which, therefore, may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

USF Health will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. USF Health does not endorse any products or services.

Relevant financial relationships that exist between the individuals and commercial interests are noted below. This chapter specific information can be accessed at any time, by clicking the “More Info” link at the top of each textbook chapter.

Editor In Chief

Quentin M. Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP

Professor of Experimental Hepatology
Consultant Hepatologist
Institute of Cellular Medicine
Newcastle University
Newcastle Upon Tyne, United Kingdom

Quentin M. Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP, has disclosed that he has received funds for research support from AbbVie, Allergan/Tobira, AstraZeneca, GlaxoSmithKline, Glympse Bio, Novartis, Pfizer, and Vertex; consulting fees from Abbott, Acuitas Medical, Allergan/Tobira, Blade, BNN Cardio, Cirius, CymaBay, E3Bio, EcoRl, Galmed, Genfit, Gilead Sciences, Grunthal, Histolndex, lndalo, lmperial lnnovations, lntercept Pharma Europe, lnventiva, lQVlA, Janssen, Kenes, Lilly, Madrigal, Medlmmune, Metacrine, NewGene, NGMBio, North Sea Therapeutics, Novartis, Novo Nordisk, Pfizer, Poxel, ProSciento, Raptor Pharma, Servier, and Viking Therapeutics; fees for non-CME/CE services from Abbott, Allergan/Tobira, Bristol-Myers Squibb, Falk, Fishawack, Genfit, and Gilead Sciences; and maintains active research collaborations (including those supported through the EU IMI2 LITMUS Consortium*) with AbbVie, Allergan/Tobira, Antaros Medical,* AstraZeneca, Boehringer lngelheim lnternational,* Ellegaard Gottingen Minipigs,* Exalenz ,* Genfit,* GlaxoSmithKline, Glympse Bio, Histolndex, lntercept Pharma Europe,* iXscient, Lilly,* Nordic Bioscience,* Novartis,* Novo Nordisk,* One Way Liver Genomics,* Perspectum Diagnostics,* Pfizer,* Sanofi-Aventis Deutschland,* SomaLogic,* and Takeda Pharmaceuticals lnternational.*

Author

Philip N. Newsome, PhD, FRCPE

Professor of Hepatology
University of Birmingham
Birmingham, United Kingdom

Philip N. Newsome, PhD, FRCPE, has disclosed that he has received consulting fees from Gilead Sciences, Intercept, Novo Nordisk, and Pfizer.

Staff

Megan Cartwright, PhD

Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Jennifer M. Blanchette, PhD

Managing Editor

Jennifer M. Blanchette, PhD, has no relevant conflicts of interest to report.

Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no relevant conflicts of interest to report.

Elaine P. Seeskin

Editorial Contributor

Elaine P. Seeskin has no relevant conflicts of interest to report.

Planning Committee, USF Health OCPD staff members and the peer/content reviewers for this activity have no relevant financial relationships to disclose. Disclosures are on file at the USF Health Office of Continuing Professional Development.

Disclaimer

The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Unapproved Use Disclosure

USF Health requires CME/CE faculty to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may/will discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

USF Health Privacy Policy

USF Health Office of Continuing Professional Development (OCPD) has created a privacy policy to demonstrate our commitment to guarding the privacy of our clients. The following statements disclose our practices on gathering and disseminating information for this web site. The OCPD has security measures in place to protect the loss, misuse, and alteration of the information under our control. The OCPD does not share or sell any individual’s contact information, financial information, or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

If you have any questions about this privacy policy, please contact USF Health OCPD, at cpdsupport@health.usf.edu.

Equal Opportunity

USF is an Equal Opportunity/ Equal Access/ Affirmative Action Institution.

Contact Information

If you have technical queries about using this site, please contact: techhelp@clinicaloptions.com.

If you have credit related queries, please contact: cpdsupport@health.usf.edu.

inPractice Hepatology current certification period
Release Date: January 1, 2019
Expiration Date: June 30, 2019

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the management of patients with viral hepatitis.

Goal:

The goal of this activity is to provide a comprehensive clinical reference resource on the prevention, diagnosis, and treatment of viral hepatitis.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

Commercial Support

This program is supported by educational grants from AbbVie and Gilead Sciences.


inPractice HIV current certification period
Release Date: September 26, 2019
Expiration Date: September 25, 2020

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the management of patients with HIV.

Goal:

The goal of this activity is to provide a comprehensive clinical reference resource on the prevention, diagnosis, and treatment of HIV disease.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

Commercial Support:

This program is supported by educational grants from Gilead Sciences and ViiV Healthcare.


For inPractice Hepatology

Physician Continuing Medical Education (for Point of Care CME activities)
USF University

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and inPractice Resources. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF

USF Health designates this internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 CreditTM .Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For inPractice HIV

Physician Continuing Medical Education (for Point of Care CME activities)
CCO

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CCO designates this internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Credit (Point of Care CME)

inPractice offers physicians AMA PRA Category 1 CreditTM for participation in this individual Internet point-of-care activity. Physicians may claim 0.5 credits per search. To claim point-of-care (PoC) CME credit through inPractice, eligible physicians must complete the following steps:

  1. Register online at http://www.inpractice.com
  2. Execute a search or submit a clinical question
  3. Review the applicable clinical sources
  4. Click the "Claim CME Credit" button at the top right corner of the content you have viewed
  5. Complete the simple evaluation questions addressing clinical application of learnings from the sources you have consulted

After submitting the evaluation, you will be presented with your online CME certificate as a pdf file. Records of all CME activities completed can be found on the "My CME" page.